Link Pharma Chem Ltd
Incorporated in 1986, Link Pharma Chem Ltd is engaged in the manufacturing and job work of organic intermediates.
- Market Cap ₹ 16.0 Cr.
- Current Price ₹ 36.0
- High / Low ₹ 50.9 / 28.2
- Stock P/E
- Book Value ₹ 28.5
- Dividend Yield 0.00 %
- ROCE -3.00 %
- ROE -7.81 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -0.03% over past five years.
- Company has a low return on equity of -4.49% over last 3 years.
- Debtor days have increased from 56.4 to 72.0 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
23.59 | 17.58 | 12.35 | 16.10 | 23.53 | 24.50 | 25.47 | 34.81 | 53.56 | 38.76 | 29.90 | 25.43 | 24.40 | |
21.25 | 18.36 | 12.16 | 13.56 | 20.75 | 22.48 | 22.05 | 31.67 | 50.02 | 36.04 | 30.55 | 25.30 | 24.18 | |
Operating Profit | 2.34 | -0.78 | 0.19 | 2.54 | 2.78 | 2.02 | 3.42 | 3.14 | 3.54 | 2.72 | -0.65 | 0.13 | 0.22 |
OPM % | 9.92% | -4.44% | 1.54% | 15.78% | 11.81% | 8.24% | 13.43% | 9.02% | 6.61% | 7.02% | -2.17% | 0.51% | 0.90% |
0.26 | 0.21 | 2.39 | -0.43 | 0.07 | 0.19 | -0.69 | -0.15 | 0.46 | -0.15 | 0.64 | 0.19 | 0.13 | |
Interest | 1.14 | 1.44 | 0.91 | 0.80 | 0.62 | 0.39 | 0.36 | 0.44 | 0.45 | 0.76 | 0.87 | 0.78 | 0.66 |
Depreciation | 0.79 | 1.13 | 0.93 | 0.83 | 0.86 | 0.89 | 0.93 | 0.87 | 0.93 | 0.92 | 1.03 | 0.94 | 0.96 |
Profit before tax | 0.67 | -3.14 | 0.74 | 0.48 | 1.37 | 0.93 | 1.44 | 1.68 | 2.62 | 0.89 | -1.91 | -1.40 | -1.27 |
Tax % | 23.88% | -29.94% | 20.27% | 54.17% | 17.52% | 29.03% | 34.03% | 35.12% | 28.24% | 26.97% | -28.80% | -26.43% | |
0.52 | -2.20 | 0.59 | 0.23 | 1.13 | 0.66 | 0.95 | 1.08 | 1.88 | 0.65 | -1.36 | -1.03 | -0.93 | |
EPS in Rs | 1.17 | -4.95 | 1.33 | 0.52 | 2.54 | 1.49 | 2.14 | 2.43 | 4.23 | 1.46 | -3.06 | -2.32 | -2.10 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 0% |
3 Years: | -22% |
TTM: | -21% |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | % |
3 Years: | % |
TTM: | -288% |
Stock Price CAGR | |
---|---|
10 Years: | 13% |
5 Years: | 11% |
3 Years: | -3% |
1 Year: | -10% |
Return on Equity | |
---|---|
10 Years: | 3% |
5 Years: | 1% |
3 Years: | -4% |
Last Year: | -8% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 |
Reserves | 6.23 | 3.93 | 4.52 | 4.16 | 5.35 | 5.94 | 6.99 | 8.12 | 10.03 | 10.60 | 9.27 | 8.22 |
9.08 | 10.80 | 5.41 | 4.73 | 2.71 | 2.64 | 3.56 | 3.66 | 6.39 | 8.76 | 9.22 | 5.78 | |
6.60 | 7.35 | 3.46 | 3.81 | 4.69 | 4.99 | 3.98 | 9.82 | 8.10 | 8.66 | 3.02 | 4.86 | |
Total Liabilities | 26.35 | 26.52 | 17.83 | 17.14 | 17.19 | 18.01 | 18.97 | 26.04 | 28.96 | 32.46 | 25.95 | 23.30 |
14.59 | 17.51 | 10.13 | 9.57 | 9.76 | 9.14 | 8.81 | 8.71 | 8.79 | 9.00 | 9.94 | 9.28 | |
CWIP | 1.92 | 0.00 | 0.00 | 0.00 | 0.01 | 0.43 | 0.00 | 0.00 | 0.21 | 0.00 | 0.00 | 0.00 |
Investments | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 4.52 | 3.64 | 2.93 | 2.06 |
9.82 | 8.99 | 7.68 | 7.54 | 7.39 | 8.41 | 10.13 | 17.30 | 15.44 | 19.82 | 13.08 | 11.96 | |
Total Assets | 26.35 | 26.52 | 17.83 | 17.14 | 17.19 | 18.01 | 18.97 | 26.04 | 28.96 | 32.46 | 25.95 | 23.30 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.87 | 5.13 | -3.91 | 2.23 | 3.79 | 1.36 | 2.95 | 4.84 | -1.26 | -1.71 | -0.03 | 2.69 | |
-1.14 | -3.27 | 8.72 | -0.73 | -1.15 | -0.96 | -1.66 | -2.16 | -4.97 | -0.08 | 0.41 | 1.53 | |
0.30 | -0.87 | -5.75 | -1.48 | -2.63 | -0.46 | 0.55 | -0.33 | 2.27 | 1.61 | -0.41 | -4.21 | |
Net Cash Flow | 0.03 | 0.99 | -0.94 | 0.02 | 0.00 | -0.05 | 1.85 | 2.35 | -3.95 | -0.17 | -0.03 | 0.00 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 51.06 | 63.74 | 68.86 | 49.42 | 49.33 | 45.29 | 71.51 | 58.19 | 36.60 | 34.18 | 62.87 | 72.05 |
Inventory Days | 143.28 | 125.34 | 277.34 | 285.97 | 96.96 | 92.54 | 60.04 | 51.35 | 47.68 | 209.23 | 135.89 | 166.94 |
Days Payable | 110.60 | 94.59 | 81.61 | 202.93 | 124.25 | 108.98 | 110.86 | 140.70 | 45.37 | 112.90 | 38.51 | 101.21 |
Cash Conversion Cycle | 83.74 | 94.49 | 264.59 | 132.47 | 22.05 | 28.85 | 20.68 | -31.16 | 38.90 | 130.51 | 160.24 | 137.78 |
Working Capital Days | -9.90 | -46.92 | -6.80 | 0.23 | 31.64 | 31.43 | 51.45 | 10.49 | 14.17 | 26.74 | 5.13 | 15.07 |
ROCE % | 9.32% | -8.74% | -3.64% | 13.00% | 15.41% | 10.34% | 18.71% | 14.61% | 13.16% | 6.72% | -4.79% | -3.00% |
Documents
Announcements
-
Intimation Regarding Dispatch Of Letter Containing Web Link Of Annual Report Pursuant To Regulation 36(1)(B) Of SEBI (LODR) Regulations, 2015.
2d - Dispatch of annual report link and AGM details for FY 2024-25; e-voting from Sept 6-8, AGM on Sept 9, 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - Newspaper advertisement of notice of 40th Annual General Meeting.
-
Intimation Of Book Closure Pursuant To Section 91 Of Companies Act, 2013 And Regulation 42 Of The SEBI (LODR) Regulations, 2015 For The Purpose Of 40Th Annual General Meeting.
13 Aug - Book closure from 3-9 Sept 2025 for 40th AGM; e-voting cut-off on 2 Sept 2025.
- Notice Convening 40Th Annual General Meeting Of The Company Scheduled To Be Held On Tuesday, 09Th September, 2025 At 11:30 A.M. (IST). 13 Aug
-
Reg. 34 (1) Annual Report.
13 Aug - Link Pharma Chem files FY 2024-25 Annual Report and AGM notice for meeting on 09 Sept 2025 via VC.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
Company manufactures and exports multi range intermediates for pharmaceutical, agro industries and specialty chemicals. It is also engaged in custom synthesis/contract manufacturing for multistage synthesis for small, medium, large companies.